In animal models of obesity, administration of dual GLP‐1R/GCGR agonists resulted in superior weight loss, lower glucose levels, and reduced food intake compared with pure GLP‐1R agonists alone.118, 119, 120, 121. The gene discussed is GLP1R; the disease is Obesity.